Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Sigmund who wrote (1750)	6/24/1998 11:20:00 AM
From: Frank Buck	Read Replies (1) \| Respond to of 1894

Sigmund, Do you have an asterisk next to * ACMIC indicating news? I do not.... but I show an asterisk next to * ACMI which has been leftover in the personal Yahoo profile since earlier this year. NPTH is getting another spanking and perhaps it is justified. AccuMed may be directly responsible..... AccuMed International, Inc. (Nasdaq: ACMI) today announced that a major Chicago teaching hospital and a large integrated healthcare provider located in the Pacific Northwest have contracted for the AcCell(TM) Cytopathology System in their cytology laboratories. NeoPath is located in the Pacific Northwest and has let a large potential customer slip away from them.... turf war ?? Should NPTH sell units in Illinois perhaps...... I had better not say it